- Home
- PCRX vs HKD Comparison
PCRX vs HKD Comparison
Compare PCRX & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- HKD
- Stock Information
- Founded
- PCRX 2006
- HKD 2003
- Country
- PCRX United States
- HKD France
- Employees
- PCRX N/A
- HKD N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- HKD Finance: Consumer Services
- Sector
- PCRX Health Care
- HKD Finance
- Exchange
- PCRX Nasdaq
- HKD Nasdaq
- Market Cap
- PCRX 604.7M
- HKD 595.6M
- IPO Year
- PCRX 2011
- HKD 2022
- Fundamental
- Price
- PCRX $25.14
- HKD $2.73
- Analyst Decision
- PCRX Buy
- HKD
- Analyst Count
- PCRX 10
- HKD 0
- Target Price
- PCRX $27.60
- HKD N/A
- AVG Volume (30 Days)
- PCRX 644.2K
- HKD 363.1K
- Earning Date
- PCRX 02-27-2025
- HKD 01-01-0001
- Dividend Yield
- PCRX N/A
- HKD N/A
- EPS Growth
- PCRX N/A
- HKD N/A
- EPS
- PCRX N/A
- HKD 0.33
- Revenue
- PCRX $694,957,000.00
- HKD $27,776,448.00
- Revenue This Year
- PCRX $4.83
- HKD N/A
- Revenue Next Year
- PCRX $2.16
- HKD N/A
- P/E Ratio
- PCRX N/A
- HKD $8.32
- Revenue Growth
- PCRX 4.40
- HKD N/A
- 52 Week Low
- PCRX $11.16
- HKD $2.55
- 52 Week High
- PCRX $34.01
- HKD $5.80
- Technical
- Relative Strength Index (RSI)
- PCRX 75.74
- HKD 44.80
- Support Level
- PCRX $18.18
- HKD $2.68
- Resistance Level
- PCRX $22.36
- HKD $2.78
- Average True Range (ATR)
- PCRX 1.21
- HKD 0.14
- MACD
- PCRX 0.36
- HKD 0.01
- Stochastic Oscillator
- PCRX 98.85
- HKD 29.41
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.